1 recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Renal Cell Cancer, Recurrent: new trials by email Literature Review of Renal Cell Cancer, Recurrent trials Research Report on Renal Cell Cancer, Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC 177Lu-TLX250 - ccRCC, Renal Cell Carcinoma (Kidney Cancer) | Phase 3 | Recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 40 | 2026-03-25 | 2026-04-01 |
| Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy Concomitant coaching - Renal Cell Carcinoma, Metastatic, Renal Cell Cancer, Recurrent | Phase 3 | Terminated | AIO-Studien-gGmbH | 121 | 2017-01-18 | 2025-02-14 |
Carcinoma, Renal Cell (2) · Recurrence (2) · Kidney Neoplasms (1) · Neoplasm Metastasis (1)
Adenocarcinoma (2) · Carcinoma (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
AIO-Studien-gGmbH (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1)
Australia (1) · Germany (1)
2016 (1)